PG vs SRPT · P/E 25, rev $84.28B vs rev $1.90B
Procter & Gamble Company (PG) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
PG currently screens at market cap $373.53B and trailing P/E 25.3. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the PG and SRPT stock pages for the full models.
Not investment advice.